Sartorius Stedim Biotech and Refine Technology are collaborating for the development of a high-density cell cultivation.
The platform will enable a connection of the ATF System to SSB’s single-use Biostat bioreactors.
The joint development project responds to the market demand for more effective connectivity between equipment from different suppliers to enable development of streamlined systems. “We decided to work together, based on market feedback, to create a platform for late-stage clinical and commercial-scale biopharmaceutical manufacturing processes. Our objective is to give our customers the confidence of a well-thought-out system featuring high-density cell cultivation via perfusion and concentrated fed-batch processes,” states Christel Fenge, vice president of fermentation technologies at SSB.
Release Date: January 23, 2012
Source: Sartorius Stedim Biotech
